Metraipolis › archive › dc_6bb4ee3101b0

Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment — Europe PMC PMID:41899590

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41899590
DOI
10.3390/cancers18060989
License (as archived)
solo-consultazione
Archived
2026-11-04T06:09:21.478Z
SHA-256 of the archived text
638767ad79c75572c7b2f0e9fffbcb4f29049cceb5ac85543fd616303a6e5950
Stable URL of this page
https://metraipolis.com/documento/dc_6bb4ee3101b0

How to cite

Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment — Europe PMC PMID:41899590 — Europe PMC (en), https://europepmc.org/article/MED/41899590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6bb4ee3101b0 (Metraipolis archive dc_6bb4ee3101b0, sha256 638767ad79c75572c7b2f0e9fffbcb4f29049cceb5ac85543fd616303a6e5950)
BibTeX
@misc{dc6bb4ee3101b0,
  title = {Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment — Europe PMC PMID:41899590},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41899590},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6bb4ee3101b0; sha256 638767ad79c75572c7b2f0e9fffbcb4f29049cceb5ac85543fd616303a6e5950},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899590. Agents can read the archived copy with the MCP tool read_document.